Meagan Good is raising awareness for an issue that hits close to home.
The actress will be shedding light on endometrial cancer through a partnership with FORCE, SHARE, Black Health Matters, and Eisai Inc. for the Spot Her® campaign. According to a press release, the campaign hopes to help many across the globe pinpoint the early signs of endometrial cancer.
The press release also revealed Good once had “a uterine cancer scare” after a doctor found an irregularity in her uterus. The actress later had surgery to remove the tissue as it was deemed that it could possibly become cancerous. Now, Good takes greater precautions for her gynecologic health and she hopes more are inspired to follow suit through the campaign.
“Gynecologic health is an important conversation to have at any age, but it’s not often discussed, especially in the Black community,” said Good, according to a press release. “I’m not afraid to have open and honest conversations with my friends, family and doctor about gynecologic health and I want to encourage everyone, particularly the Black community, to do the same so more people can identify potential signs of endometrial cancer early. As women, it’s important that we support each other, speak up about gynecologic symptoms and advocate for our health when visiting our doctor.”
Spot Her Campaign
The Spot Her campaign will feature a virtual walk from March 30, 2022, through June 22, 2022. Good will be joining the charitable race and all are welcome to join. What’s more, Charity Footprints will offer free registration for the first 1,000 participants.
For each mile logged through the Charity Footprints’ website or each use of the hashtag #SpotHerforEC on social platforms, Eisai will donate a one-dollar donation to FORCE or SHARE.
“Now in its second year, the Spot Her campaign exemplifies Eisai’s human health care mission to put patients first and address the unmet needs of those who are underserved. Partnering with SHARE, FORCE and Black Health Matters empowers our efforts to better understand the unmet needs in these communities and help address them,” said Teresa Cronin, Vice President of Corporate Communications and Patient Advocacy at Eisai Inc., in a statement. “By raising our voices in unison with organizations that share our commitment to educating about endometrial cancer and helping to address intersectional factors contributing to disparities in care, we aim to make a meaningful difference for those who need it most.”
To register, click here.